LeJeune Puetz Investment Counsel LLC Increases Stake in Monsanto Company (NYSE:MON)
LeJeune Puetz Investment Counsel LLC raised its position in Monsanto Company (NYSE:MON) by 14.2% during the second quarter, Holdings Channel reports. The fund owned 3,025 shares of the basic materials company’s stock after buying an additional 375 shares during the period. LeJeune Puetz Investment Counsel LLC’s holdings in Monsanto were worth $358,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. raised its stake in Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after buying an additional 25,140,936 shares during the last quarter. York Capital Management Global Advisors LLC raised its stake in Monsanto by 58.4% in the first quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock valued at $462,662,000 after buying an additional 1,506,057 shares in the last quarter. Flossbach Von Storch AG raised its stake in Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock valued at $462,920,000 after buying an additional 1,034,400 shares in the last quarter. UBS Asset Management Americas Inc. raised its stake in Monsanto by 55.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,181,090 shares of the basic materials company’s stock valued at $246,899,000 after buying an additional 775,520 shares in the last quarter. Finally, MARSHALL WACE ASIA Ltd purchased a new stake in Monsanto during the first quarter valued at approximately $63,977,000. Hedge funds and other institutional investors own 75.31% of the company’s stock.
Shares of Monsanto Company (MON) traded down 0.33% during midday trading on Friday, hitting $116.55. 1,012,471 shares of the company’s stock were exchanged. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The firm has a market cap of $51.20 billion, a PE ratio of 25.17 and a beta of 1.07. The stock’s 50-day moving average price is $117.47 and its 200 day moving average price is $115.08.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The company’s revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.17 EPS. Equities research analysts forecast that Monsanto Company will post $4.89 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.85%. Monsanto’s payout ratio is currently 46.75%.
Several analysts recently commented on the stock. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research report on Thursday, June 29th. Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 price target (up previously from $120.00) on shares of Monsanto in a research report on Thursday, June 29th. Barclays PLC raised their price target on shares of Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, June 29th. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Tuesday, July 4th. Finally, Citigroup Inc. restated a “neutral” rating and set a $126.00 price target (up previously from $125.00) on shares of Monsanto in a research report on Monday, July 10th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have assigned a buy rating to the company’s stock. Monsanto currently has a consensus rating of “Hold” and a consensus price target of $123.15.
In related news, SVP Janet M. Holloway sold 3,337 shares of the stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $118.00, for a total transaction of $393,766.00. Following the completion of the sale, the senior vice president now owns 44,405 shares of the company’s stock, valued at approximately $5,239,790. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the sale, the executive vice president now directly owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 74,470 shares of company stock worth $8,791,281. Insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.